Author:
Pandita Deepti,Ahuja Alka,Lather Viney,Benjamin Biju,Dutta Tathagata,Velpandian Thirumurthy,Khar Roop Krishen
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference44 articles.
1. Gregory R, DeLisa AF. Paclitaxel: a new antineoplastic agent for refractory ovarian cancer. Clin Pharm. 1993;12:401–15.
2. Sonnichsen DS et al. Saturable pharmacokinetics and paclitaxel pharmacodynamics in children with solid tumors. J Clin Oncol. 1994;12:532–8.
3. Kramer I, Heuser A. Paclitaxel pharmaceutical and pharmacological issues. Eur Hosp Pharm. 1995;1:37–41.
4. Straubinger RM. Biopharmaceutics of paclitaxel (Taxol): formulation, activity, and pharmacokinetics. In: Suffness M, editor. Taxol®: science and applications. New York: CRC press; 1995. p. 237–54.
5. Kasim NA et al. Molecular properties of WHO essential drugs and provisional biopharmaceutics classification. Mol Pharm. 2003;1:85–96.
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献